19.60
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLP?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$18.05
Offen:
$16.87
24-Stunden-Volumen:
901.52K
Relative Volume:
2.35
Marktkapitalisierung:
$394.87M
Einnahmen:
$66.98M
Nettoeinkommen (Verlust:
$9.65M
KGV:
40.83
EPS:
0.48
Netto-Cashflow:
$10.19M
1W Leistung:
+8.23%
1M Leistung:
+0.00%
6M Leistung:
+11.81%
1J Leistung:
-30.52%
Simulations Plus Inc Stock (SLP) Company Profile
Firmenname
Simulations Plus Inc
Sektor
Branche
Telefon
661-723-7723
Adresse
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Vergleichen Sie SLP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SLP
Simulations Plus Inc
|
19.60 | 363.65M | 66.98M | 9.65M | 10.19M | 0.48 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-09-30 | Eingeleitet | TD Cowen | Hold |
| 2025-07-15 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-11-15 | Eingeleitet | Stephens | Overweight |
| 2024-07-29 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-06-28 | Eingeleitet | William Blair | Outperform |
| 2023-05-09 | Eingeleitet | BTIG Research | Buy |
| 2021-10-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2021-01-12 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-16 | Eingeleitet | Raymond James | Outperform |
| 2020-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-06 | Eingeleitet | Craig Hallum | Buy |
Alle ansehen
Simulations Plus Inc Aktie (SLP) Neueste Nachrichten
Simulations Plus, Inc. SEC 10-Q Report - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Bio-Techne (TECH) and Simulations Plus (SLP) - The Globe and Mail
Simulations Plus, Inc. (NASDAQ:SLP) Q1 2026 Earnings Call Transcript - Insider Monkey
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales - TradingView — Track All Markets
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... By GuruFocus - Investing.com Canada
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Is Simulations Plus Inc. stock overvalued by current metricsJuly 2025 Closing Moves & Stepwise Swing Trade Plans - ulpravda.ru
Simulations Plus Q1 2026 Earnings Call Transcript - MarketBeat
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results - PharmiWeb.com
Simulations Plus, Inc. Q1 Profit Increases, But Misses Estimates - Nasdaq
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast By Investing.com - Investing.com Nigeria
Simulations Plus Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast - Investing.com
Simulations Plus Inc (NASDAQ:SLP) Meets Q1 Revenue Target Amid Software Segment Decline - Chartmill
Is Simulations Plus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - ulpravda.ru
Can Simulations Plus Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Capital Efficiency Focused Ideas - ulpravda.ru
Simulations Plus: Overview of First Quarter Financial Results - Bitget
Simulations Plus: Fiscal Q1 Earnings Snapshot - KVUE
SLP Adjusts FY26 Revenue Forecast Between $79M and $82M - GuruFocus
Simulations Plus Fiscal Q1 Adjusted EPS, Revenue Decrease - MarketScreener
Simulations Plus earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Simulations Plus Posts Mixed Q1 2026 Results, Reaffirms Outlook - TipRanks
Simulations Plus (NASDAQ:SLP) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS - MarketBeat
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat - Investing.com India
Simulations Plus Q1 revenue beats expectations - TradingView — Track All Markets
Simulations Plus, Inc. Reaffirms Earnings Guidance for Fiscal 2026 - MarketScreener
SLP: Analyst Maintains Rating and Raises Price Target to $19.00 - GuruFocus
Simulations Plus (NASDAQ:SLP) Price Target Raised to $19.00 - MarketBeat
Tributary Capital Management LLC Grows Stock Holdings in Simulations Plus, Inc. $SLP - MarketBeat
Will Simulations Plus Inc. stock benefit from green energy trendsMACD Trading Signals & Real-Life Case Studies You Can Follow - ulpravda.ru
An Overview of Simulations Plus's Earnings - Benzinga
North Star Investment Management Corp. Acquires 111,255 Shares of Simulations Plus, Inc. $SLP - MarketBeat
Citizens maintains Simulations Plus stock rating ahead of earnings By Investing.com - Investing.com Canada
Simulations Plus Q1 2025 Earnings Preview - MSN
Simulations Plus drives advancements in CAR-T therapy kinetics - Traders Union
What drives Simulations Plus Inc stock priceTrading Volume Trends & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat By Investing.com - Investing.com Nigeria
Simulations Plus (SLP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Signal Recap: Will Simulations Plus Inc stock outperform Nasdaq indexJuly 2025 Chart Watch & AI Optimized Trade Strategies - moha.gov.vn
Simulations Plus (NASDAQ: SLP) details 2026 meeting, auditor and equity plan votes - Stock Titan
Simulations Plus (FRA:SD3) Intrinsic Value: Projected FCF : €10.77 (As of Dec. 27, 2025) - GuruFocus
Guidance Update: Is PCGPRH stock overvalued by current metricsJuly 2025 PreEarnings & Low Volatility Stock Suggestions - moha.gov.vn
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Viridian Therapeutics (VRDN) - The Globe and Mail
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Simulations Plus (SLP) Highlights FDA Alignment as Citizens Maintains Market Perform - Insider Monkey
Diluted shares outstanding of Simulations Plus, Inc. – FWB:SD3 - TradingView — Track All Markets
Current ratio of Simulations Plus, Inc. – FWB:SD3 - TradingView — Track All Markets
Can Simulations Plus Inc. stock deliver strong Q4 earnings2025 Historical Comparison & High Return Stock Watch Alerts - DonanımHaber
Will Simulations Plus Inc. stock attract more institutional investorsQuarterly Profit Report & Weekly Top Gainers Trade List - DonanımHaber
Trading Recap: Will Simulations Plus Inc. stock benefit from green energy trendsMarket Sentiment Report & Fast Gaining Stock Reports - Улправда
Finanzdaten der Simulations Plus Inc-Aktie (SLP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):